Farms.com Home   News

It’s time to drop emissions caps and re-embrace intensity

The federal government got smart on the firearms law.

It’s time it got smart on the fertilizer emissions target as well as its oil emissions reduction targets. It’s time to back away from caps that ignore the role of Canada as a global leader in responsible commodity production.

Canada needs to champion low-emissions commodity production in a world that desperately needs safe, secure and regulated production.

We don’t need less production from Canada. We need more. The world needs what we produce.

The firearms amendments, which would have banned assault weapons but also appeared to catch many legitimate hunting guns in its net, caused much bad political blood to be spilled across the country, became yet another poisonous culture war divide, distracted the government and the opposition parties from productive issues, and created a scorching disincentive for the government to implement focused and worthwhile gun control regulations.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.